CompoAtlas

Xinshenning Tablet

Natural health product licensed in Canada

Licence holder
T.C. Unicorn Ltd.
NPN or DIN-HM
80034381
Status
Active licence
Licence date
3 August 2012
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Polygala tenuifolia

Source : Racine

Extraction ratio : 7.9:1

Dry plant equivalent : 167 mg

21 mgNot calculated
Poria cocos

Source : Sclerotium

Extraction ratio : 7.9:1

Dry plant equivalent : 167 mg

21 mgNot calculated
Glycyrrhiza uralensis

Source : Racine

83 mgNot calculated
Ziziphus spinosa

Source : Graine(s)

Extraction ratio : 7.9:1

Dry plant equivalent : 250 mg

32 mgNot calculated

Non-medicinal ingredients

Dextrine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 4 Comprimé ; maximum: 6 Comprimé3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

This traditional Chinese medicine helps nourish the blood, eliminate irritability, quiet the heart, and calm the spirit. It is used for deficiency in the heart and liver, marked by insomnia, irritability, lassitude, and lack of appetite.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80034381

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line